Therapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidence
Cognitive decline is believed to be associated with neurodegenerative processes involving excitotoxicity, oxidative damage, inflammation, and microvascular and blood-brain barrier dysfunction. Interestingly, research evidence suggests upregulated synthesis of lipid signaling molecules as an endogeno...
Main Authors: | Marco Colizzi, Riccardo Bortoletto, Chiara Colli, Enrico Bonomo, Daniele Pagliaro, Elisa Maso, Gianfranco Di Gennaro, Matteo Balestrieri |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1038122/full |
Similar Items
-
Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence
by: Riccardo Bortoletto, et al.
Published: (2022-01-01) -
Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence
by: Marco Colizzi, et al.
Published: (2021-04-01) -
Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence
by: Riccardo Bortoletto, et al.
Published: (2023-07-01) -
Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis
by: Riccardo Bortoletto, et al.
Published: (2022-08-01) -
Effects of Palmitoylethanolamide on Neurodegenerative Diseases: A Review from Rodents to Humans
by: Eugenia Landolfo, et al.
Published: (2022-05-01)